Armata Pharmaceuticals Inc

ARMPAMEX · USD
2.99USD0.00 (-22.74%)
115

Armata Pharmaceuticals Inc (ARMP) Historical Volatility

ARMP's 30 day historical volatility is 140.86%, in the 95th percentile of readings over the past year. This is a high percentile, meaning Armata Pharmaceuticals Inc shares have swung far more than usual. ARMP's 30 day implied volatility sits at 167.36%, with an IV Rank of 12.30%, leaving IV 26.50 points above historical volatility. This means options are pricing in more movement than the stock has actually delivered, as of Nov 13, 2026.

Read more

Tracking ARMP historical volatility helps you see how much Armata Pharmaceuticals Inc's stock price has actually moved, giving you a baseline for whether option premiums look fair, cheap, or expensive. While implied volatility shows what the market expects, ARMP's HV, also known as realized volatility, shows what actually happened. Use our scanner to monitor ARMP 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.

Historical volatility is the annualized standard deviation of a stock's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. ARMP's 30 day historical volatility, or ARMP HV, is one of the most widely watched readings because it balances responsiveness with stability. Comparing ARMP's HV to its implied volatility reveals the volatility risk premium. When IV sits well above HV, options are pricing in more movement than the stock has actually delivered, giving option sellers an edge. When HV runs hot relative to IV, options are pricing in less movement than the stock has delivered, and buyers may be underpaying for it.

Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has a partnership agreement with Merck & Co. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.

Historical Volatility

HV Percentile
95thHV Percentile
High

Historical movement is elevated versus the past year. The stock has been unusually active.

Historical Volatility (30d)140.86%

HV Percentile95th

Implied Volatility (30d)167.36%

IV Rank12.30%

IV Minus HV+26.50%

As of Nov 13, 2026

IV vs HV
Implied Volatility (IV) vs Historical Volatility (HV) over the past month.

As of Nov 13, 2026

IV - HV Difference
Difference between IV and HV over time. Positive values indicate IV > HV.

As of Nov 13, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →